These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 24769034)
1. GALNT4 predicts clinical outcome in patients with clear cell renal cell carcinoma. Liu Y; Liu W; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J J Urol; 2014 Nov; 192(5):1534-41. PubMed ID: 24769034 [TBL] [Abstract][Full Text] [Related]
2. Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma. Wu Q; Yang L; Liu H; Zhang W; Le X; Xu J Ann Surg Oncol; 2015 Jul; 22(7):2446-53. PubMed ID: 25391266 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of p21-activated kinase 6 expression in patients with clear cell renal cell carcinoma. Liu W; Liu H; Liu Y; Xu L; Zhang W; Zhu Y; Xu J; Gu J Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S575-83. PubMed ID: 24715215 [TBL] [Abstract][Full Text] [Related]
4. β1,6-N-acetylglucosaminyltransferase V predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection. Liu Y; Liu H; Liu W; Zhang W; An H; Xu J World J Urol; 2015 Nov; 33(11):1791-9. PubMed ID: 25630622 [TBL] [Abstract][Full Text] [Related]
5. CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinoma. An H; Xu L; Chang Y; Zhu Y; Yang Y; Chen L; Lin Z; Xu J Eur J Cancer; 2015 Sep; 51(14):1953-61. PubMed ID: 26188847 [TBL] [Abstract][Full Text] [Related]
6. p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma. Zhu Y; Xu L; An H; Liu W; Wang Z; Xu J Int J Urol; 2015 May; 22(5):447-53. PubMed ID: 25711487 [TBL] [Abstract][Full Text] [Related]
7. High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma. Pan D; Xu L; Liu H; Zhang W; Liu W; Liu Y; Fu Q; Xu J Cancer Sci; 2015 May; 106(5):592-7. PubMed ID: 25702890 [TBL] [Abstract][Full Text] [Related]
9. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease. Blute ML; Amling CL; Bryant SC; Zincke H Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850 [TBL] [Abstract][Full Text] [Related]
10. The Presence of Vascular Mimicry Predicts High Risk of Clear Cell Renal Cell Carcinoma after Radical Nephrectomy. Zhou L; Chang Y; Xu L; Liu Z; Fu Q; Yang Y; Lin Z; Xu J J Urol; 2016 Aug; 196(2):335-42. PubMed ID: 26970566 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. Yoo C; Song C; Hong JH; Kim CS; Ahn H J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101 [TBL] [Abstract][Full Text] [Related]
12. Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma. Liu Y; Xu L; Zhu Y; Zhang W; Liu W; Liu H; Xu J Urol Oncol; 2015 Mar; 33(3):112.e1-8. PubMed ID: 25499921 [TBL] [Abstract][Full Text] [Related]
13. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492 [TBL] [Abstract][Full Text] [Related]
14. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy. Harada K; Miyake H; Kusuda Y; Fujisawa M BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620 [TBL] [Abstract][Full Text] [Related]
15. Notch1 predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection. An H; Zhu Y; Xu L; Chen L; Lin Z; Xu J Urology; 2015 Feb; 85(2):483.e9-483.e14. PubMed ID: 25559729 [TBL] [Abstract][Full Text] [Related]
16. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733 [TBL] [Abstract][Full Text] [Related]
17. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival. Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115 [TBL] [Abstract][Full Text] [Related]
18. [Pathological prognostic indicators in renal cell carcinoma]. Rey Rey J; León Ramírez D; López García S; Fernández Vázquez P; Benavente Delgado J; Ojea Calvo A Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135 [TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of intratumoral C-reactive protein expression in patients with clear cell renal cell carcinoma. Can C; Acikalin MF; Ozen A; Dundar E Urol Int; 2014; 92(3):270-5. PubMed ID: 24356040 [TBL] [Abstract][Full Text] [Related]
20. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma. Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]